BRAF inhibitors in cancer therapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference91 articles.
1. Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use;Ascierto;J Transl Med,2012
2. Dabrafenib: first global approval;Ballantyne;Drugs,2013
3. Gossypin as a novel selective dual inhibitor of V-RAF murine sarcoma viral oncogene homolog B1 and cyclin-dependent kinase 4 for melanoma;Bhaskaran;Mol Cancer Ther,2013
4. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma;Bollag;Nature,2010
5. Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function;Boni;Cancer Res,2010
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Apoptotic Effects of Rapamycin and Vemurafenib in Colorectal Cancer;Uludağ Üniversitesi Tıp Fakültesi Dergisi;2023-12-31
2. Targeting CRAF kinase in anti-cancer therapy: progress and opportunities;Molecular Cancer;2023-12-18
3. Detection of isoforms and genomic alterations by high-throughput full-length single-cell RNA sequencing in ovarian cancer;Nature Communications;2023-11-27
4. Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches;Cancers;2023-11-13
5. BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature;Cancers;2023-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3